NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?

E-ISSN： 2212-3962|10|1|60-64

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.10, Iss.1, 2015-04, pp. : 60-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Laboratory characteristics of ischemic stroke patients with atrial fibrillation on or off therapeutic warfarin

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1347-1351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure

By Lee Andrea Crowther Mark

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 249-258

Springer Publishing Company

Access to resources Recommend Favorite

Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 3, 2015-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alternatives to Warfarin for Thromboembolism Prophylaxis in Nonrheumatic Atrial Fibrillation: Current Topics in the Management of Atrial Fibrillation

By Artang Ramin Vidaillet Humberto

Journal of Interventional Cardiac Electrophysiology, Vol. 10, Iss. 1, 2004-02 ,pp. : 33-44

Springer Publishing Company

Access to resources Recommend Favorite

Why is Warfarin Underutilized in Patients with Atrial Fibrillation?: Current Topics in the Management of Atrial Fibrillation

By Flaker Greg C. Schutz John

Journal of Interventional Cardiac Electrophysiology, Vol. 10, Iss. 1, 2004-02 ,pp. : 21-25

Springer Publishing Company

Access to resources Recommend Favorite